dividing line
About us


dividing line

Dermatology Research Div.
Dept. of Dermatology, L468R
3181 SW Sam Jackson Park Rd
Portland, Ore. 97239

Office: 503-418-4273
Fax: 503-418-4266



LAB DELIVERY LOCATIONS

Jacques, Kulesz-Martin and Wong labs:
Baird Hall, Rm. 2030

Blauvelt lab:
PVAMC Building 101, Rm. 525

Wang lab:
PVAMC Building 103, Rm F-221
Initiation gene profile
Initiation gene profile
Detailed supplementary information to the list of the genes published in:
Carcinogenesis vol.23 no.4 pp. 635-643, 2002
Gene expression profiling of initiated epidermal cells with benign or malignant tumor fates
Zhiping Wang, Yuangang Liu, Motomi Mori¹, Molly Kulesz-Martin²
Department of Dermatology, Oregon Health & Science University, Portland, Ore. 97239
¹Biostatistics & Bioinformatics Shared Resource, OHSU Cancer Institute
²Corresponding author: Dept. of Dermatology OP06, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Ore. 97239. Tel: (503) 220-8262 x54273; Fax: (503) 402-2817; Email: kuleszma@ohsu.edu

Cellular activity: Differentiation/barrier
Genes involved Accession# O3C O9C Mean_
291_AD
Mean_
03C_AD
Mean_
09C_AD
Affymetrix
Description
SPRR1a AF057156 10.80 NC 55.15 257.90 16.80 160909_at
filaggrin J03458 9.55 NC -4.45 88.30 30.50 100420_at
caspase-14 AF092997 3.50 NC 65.15 228.25 61.80 103837_at
suppressor of cytokine signalling-2 (SOCS-2) U88327 2.73 NC 52.93 145.13 40.73 99475_at
tumor necrosis factor, alpha-induced protein 2 L24118 -11.70 NC 35.27 -53.30 98.23 160489_at
24p3 X81627 NC 19.40 2.45 6.70 244.60 160564_at
SPRR2b AJ005560 NC -3.30 245.35 326.05 74.15 99701_f_at
brain derived neurotrophic factor X55573 NC -3.95 93.00 34.95 17.05 102727_at
GATA-binding protein 3 X55123 NC -5.60 115.43 60.93 23.73 100924_at
keratin 16 AF053235 NC -12.85 138.15 187.20 9.15 103589_at
SPRR2a AJ005559 NC -20.93 247.37 461.90 -7.40 101024_i_at
SPRR1b X91825 NC -24.07 213.97 101.37 -1.47 100445_f_at
neural visinin-like Ca2+-binding protein type 1 (NVP-1) D21165 2.95 -3.93 130.70 242.10 41.87 92995_at
cellular retinoic acid binding protein II M35523 -2.43 -2.57 347.07 143.23 142.60 100127_at
SPRR2H AJ005566 -3.03 -8.45 523.63 165.17 118.60 94121_at
SRY-box containing gene 2 X94127 -5.57 -7.93 69.33 4.70 5.80 100009_r_at
osteoblast specific factor 2 D13664 -11.33 -10.23 138.10 8.30 11.50 92593_at
Cellular activity: Proliferation
Genes involved Accession# O3C O9C Mean_
291_AD
Mean_
03C_AD
Mean_
09C_AD
Affymetrix
Description
GAS6 X59846 12.55 NC 26.25 222.55 125.55 99067_at
neuroblastoma myc-related oncogene 1 M12731 12.15 NC 21.10 213.65 19.60 103048_at
sphingosine kinase (SPHK1a) AF068748 8.40 NC -0.35 62.15 50.70 103839_at
inhibitor of DNA binding 4 (Id4) AJ001972 8.00 NC 14.67 124.93 50.80 96144_at
stromal derived factor 1, alpha L12029 7.80 NC -3.10 65.40 0.50 160511_at
metallothionein 2 K02236 6.40 NC 504.83 3049.33 1012.83 101561_at
metallothionein 1 V00835 5.13 NC 791.53 3784.70 1374.20 93573_at
insulin-like growth factor binding protein 2 X81580 5.05 NC 81.40 407.20 82.90 98627_at
stem cell factor M57647 4.77 NC 43.63 248.90 105.00 99577_at
coagulation factor II (thrombin) receptor-like 1 Z48043 3.10 NC 62.33 189.37 83.47 102915_at
stromal derived factor 1, beta L12030 2.65 NC 46.60 100.00 43.70 100112_at
phenylalkylamine Ca2+ antagonist (emopamil) binding protein X97755 -2.47 NC 287.93 122.37 188.13 96627_at
wee1 kinase D30743 -3.25 NC 95.30 47.05 55.05 101458_at
interferon regulatory factor 1 M21065 -4.17 NC 377.10 95.77 173.97 102401_at
TRA1 D78354 -4.95 NC 239.60 63.15 406.50 102839_at
Eps8 L21671 NC 7.20 65.23 130.30 330.50 103222_at
cdc2/CDC28-like protein kinase 3 (Clk3) AF033565 NC 3.15 38.95 29.85 172.90 93311_at
Dlxin-1 AB029448 NC -2.97 203.70 118.43 72.37 96703_at
Max interacting protein 1 L38822 NC -3.63 441.37 539.60 123.90 160138_at
inhibitor of DNA binding 2 (Id2) AF077861 NC -10.33 279.37 452.43 53.07 93013_at
bone morphogenetic protein 7 X56906 17.95 30.25 -61.80 138.40 218.30 93243_at
protein tyrosine phosphatase, non-receptor type substrate 1(BIT) AB018194 10.85 11.30 -0.17 99.60 93.43 103070_at
jun oncogene X12761 10.83 5.35 23.47 194.27 93.05 100130_at
c-fos V00727 3.85 3.13 59.17 171.55 159.17 160901_at
MEK5 AB019374 3.50 4.15 33.45 133.80 145.95 103592_at
parathyroid hormone-like peptide M60057 -3.05 -2.53 1260.80 490.83 511.00 104262_at
amphiregulin L41352 -4.25 2.75 508.07 132.85 1075.85 99915_at
Cellular activity: Apoptosis
Genes involved Accession# O3C O9C Mean_
291_AD
Mean_
03C_AD
Mean_
09C_AD
Affymetrix
Description
TIMP-3 U26437 28.07 NC 17.73 555.87 67.97 160519_at
interleukin 1 receptor, type II X59769 3.30 NC 18.65 70.40 24.05 102658_at
B-cell leukemia/lymphoma 6 U41465 3.23 NC 51.33 177.07 118.00 103015_at
TIP30 AF061972 -4.77 NC 65.47 5.10 73.57 103671_at
MAST205 U02313 NC 2.75 99.30 188.35 271.85 160938_at
serine protease inhibitor 6 U96700 -4.70 -7.90 253.87 58.57 80.73 98405_at
caspase 6 Y13087 -7.73 -9.33 78.70 0.47 -6.73 94458_at
Cellular activity: Cell-cell, cell-matrix interaction
Genes involved Accession# O3C O9C Mean_
291_AD
Mean_
03C_AD
Mean_
09C_AD
Affymetrix
Description
tetraspan TM4SF AF053454 9.57 NC -5.87 98.60 11.30 92555_at
cysteine-rich glycoprotein SPARC X04017 7.43 NC 15.10 100.37 -3.83 97160_at
ankyrin 3, epithelial L40631 5.55 NC 16.35 76.00 45.90 98476_at
procollagen, type IV, alpha 5 Z35168 4.00 NC 21.10 80.30 14.23 93220_at
Pcdh7 AB006758 -2.77 NC 512.00 201.80 353.10 102280_at
Ena-vasodilator stimulated phosphoprotein U72519 -4.77 NC 122.30 31.63 72.57 160667_at
secretory leukoprotease inhibitor AF002719 NC 6.50 398.57 200.60 2556.17 92858_at
integral membrane protein 2B U76253 NC -3.00 458.45 296.75 140.90 101123_at
neural cell adhesion molecule X15052 NC -4.30 161.30 47.15 37.75 100153_at
fibronectin (FN) M18194 NC -5.30 516.50 749.60 110.85 92852_at
desmocollin 3 Y11169 NC -9.10 112.55 90.25 20.85 97655_at
T-cadherin AB022100 14.85 11.50 8.85 158.30 99.20 104743_at
glypican 4 X83577 3.40 2.55 92.03 233.20 186.55 102886_at
fibulin 2 X75285 -2.53 -8.67 838.47 321.87 100.60 100928_at
minopontin X13986 -2.80 3.60 1317.07 445.13 3866.07 97519_at
transforming growth factor, beta induced, 68 kDa L19932 -2.80 -3.05 65.70 25.95 20.50 92877_at
ADAM12 D50411 -7.15 -4.95 81.10 2.20 21.80 92414_at
Cellular activity: Miscellaneous
Genes involved Accession# O3C O9C Mean_
291_AD
Mean_
03C_AD
Mean_
09C_AD
Affymetrix
Description
IL-18 D49949 12.55 NC 22.40 125.05 -9.35 102802_at
homeo box D8 X56561 4.75 NC 41.75 197.80 112.80 93221_at
mouse A-X actin J04181 4.70 NC 159.05 745.70 382.25 95705_s_at
MKP-1 X61940 3.87 NC 44.73 164.33 73.33 104598_at
hexosaminidase A U05837 3.00 NC 50.00 148.65 54.50 94840_at
downstream of tyrosine kinase 1 U78818 2.55 NC 72.40 182.85 98.10 102896_at
mouse complement component C3 K027828 -2.43 NC 127.80 54.50 217.10 93497_at
follistatin Z29532 -2.47 NC 3043.23 1191.50 1678.73 98817_at
heterogeneous nuclear ribonucleoprotein G, splice variant 1 AJ237847 -2.57 NC 218.53 51.03 276.83 97847_at
interleukin 1 alpha M14639 -3.55 NC 2533.85 725.65 2646.40 94755_at
5-3 exonuclease X91617 -5.60 NC 37.73 -23.25 53.60 98283_at
FXYD domain-containing ion transport regulator 5 U72680 -5.87 NC 109.47 27.30 148.90 103394_at
mouse protein tyrosine phosphatase (70zpep) M90388 NC 5.50 52.25 36.55 290.20 92356_at
putative glycogen storage disease type 1b AF080469 NC 4.40 19.90 25.05 85.05 97430_at
glutamate-cysteine ligase , modifier subunit(Glclr) U95053 NC 3.15 89.65 115.95 295.75 160335_at
glycerol kinase U48403 NC 2.90 111.07 147.17 321.37 97525_at
semaphorin E X85994 NC -4.00 232.40 134.35 80.10 101178_at
mouse glutathione S-transferase class mu (GST5-5) J04696 NC -5.00 191.25 136.60 35.80 93009_at
mouse calcium-dependent phospholipid binding protein M72394 NC -5.10 140.33 66.20 28.30 99513_at
adenylate cyclase 7 U12919 NC -5.10 78.20 61.10 6.45 103392_at
lysosomal acid lipase Z31689 NC -5.70 56.05 46.55 26.25 102123_at
DNA ligase I, ATP-dependent U19604 NC -7.20 180.50 149.10 74.85 92551_at
SOX11 AF009414 NC -7.47 865.17 403.80 229.97 101631_at
schwannoma-associated protein (SAM9) AF026124 NC -7.60 76.05 73.05 2.35 100607_at
cathepsin C U74683 NC -8.75 293.50 107.75 26.45 101019_at
stearoyl-coenzyme A desaturase 1 M21285 NC -12.35 327.30 302.85 52.80 94056_at
glucocortoid-regulated inflammatory prostaglandin G/H synthase (griPGHS) M88242 NC -14.17 601.90 254.13 102.77 104647_at
aldehyde dehydrogenase 3 (aldh3) AF033034 7.25 21.85 0.57 60.00 133.85 99548_at
cathepsin H U06119 3.15 4.20 128.07 398.45 521.03 94834_at
alpha-2,3-sialyltransferase D28941 2.65 2.60 107.10 317.25 246.65 95599_at
17-beta-hydroxysteroid dehydrogenase type 7 Y15733 -2.23 -4.23 165.83 77.97 46.03 94177_at
latexin D88769 -2.95 -3.20 149.00 50.05 44.55 96065_at
mouse germline interleukin 1 receptor antagonist (1L-1rn) gene L32838 -4.55 5.65 82.90 24.45 214.83 93871_at
chemokine orphan receptor 1 AF000236 -5.60 -8.57 67.17 14.97 0.47 93430_at
protease (prosome, macropain) 28 subunit AB007136 -6.33 -6.53 264.63 40.27 39.23 101510_at
cyclophilin C M74227 -29.03 -33.97 300.80 16.20 -11.77 100089_at


Murine chip MG-U74Av2 from Affymetrix® was used to measure expression changes at the initiation stage of epidermal carcinogenesis. The microarray assays were performed in the Affymetrix Microarray Core of the OHSU Gene Microarray Shared Resource. Microarray images were processed using Microarray Suite software 4.0 resulting in a relative average difference (AD) intensity measurement for each gene. Assay results were normalized among samples by globally scaling AD values to an average target intensity of 150 and difference calls were calculated using MAS 4.0. Cell clone 03C represents malignant tumor precursor and 09C represents benign tumor precursor. Fold changes (FC) in 03C and/or 09C compared to their nontransformed parental cells 291 are the average of two or three biological replicates and correspond to the relative expression intensity of genes represented by the average differences AD. Genes are organized from greatest to least according to changes in 03C followed by 09C followed by genes with expression changes in both 03C and 09C. NC indicates no change.
Last updated: April 28, 2008 | Site maintained by Michelle Bryant: dermatol@ohsu.edu